Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 166.43%3.67M | 279.02%3.4M | 227.31%10.06M | 162.26%2.8M | 755.75%4.98M | 49.54%1.38M | 79.28%898.25K | 54.53%3.07M | 1.07M | 581.82K |
| Operating revenue | 166.43%3.67M | 290.41%3.31M | 231.48%9.68M | 165.00%2.65M | 755.75%4.98M | 49.54%1.38M | 76.78%846.68K | 48.23%2.92M | --998.5K | --581.82K |
| Cost of revenue | 197.17%2.82M | 286.93%2.56M | 272.71%7.78M | 188.97%2.26M | 869.84%3.91M | 50.29%947.64K | 143.83%662.45K | 35.29%2.09M | 781.95K | 403.16K |
| Gross profit | 98.82%856.52K | 256.82%841.39K | 131.08%2.28M | 89.14%540.04K | 498.31%1.07M | 47.92%430.81K | 2.82%235.8K | 121.23%984.77K | 285.53K | 178.66K |
| Operating expense | -18.48%1.29M | -32.86%1.26M | -27.61%6.59M | -9.39%1.74M | -46.63%1.41M | -25.49%1.58M | -22.75%1.87M | 85.08%9.11M | 1.92M | 2.64M |
| Selling and administrative expenses | -22.83%1.08M | -36.32%1.02M | -30.38%5.56M | 1.76%1.55M | -51.96%1.16M | -27.42%1.4M | -29.20%1.6M | 74.94%7.99M | --1.52M | --2.41M |
| -Selling and marketing expense | 18.47%415.48K | -52.30%41.6K | 1.80%322.32K | 29.12%56.47K | -42.87%323.53K | -25.57%350.7K | -24.57%87.2K | -9.38%316.64K | --43.73K | --566.3K |
| -General and administrative expense | -36.66%663.14K | -35.39%974.71K | -31.71%5.24M | 0.95%1.49M | -54.75%835.6K | -28.02%1.05M | -29.45%1.51M | 81.92%7.67M | --1.48M | --1.85M |
| Research and development costs | 14.49%210.82K | -5.06%193.41K | -12.96%756.64K | -60.79%129.17K | 10.05%249.81K | -6.70%184.15K | 76.33%203.72K | 295.45%869.32K | --329.41K | --227.01K |
| Depreciation amortization depletion | ---- | -34.76%48.49K | 9.71%276.66K | -9.69%62.6K | ---- | ---- | 31.67%74.33K | 85.59%252.17K | --69.32K | ---- |
| -Depreciation and amortization | ---- | -34.76%48.49K | 9.71%276.66K | -9.69%62.6K | ---- | ---- | 31.67%74.33K | 85.59%252.17K | --69.32K | ---- |
| Operating profit | 62.39%-432.92K | 74.56%-416.81K | 46.85%-4.32M | 26.61%-1.2M | 86.19%-340.02K | 37.16%-1.15M | 25.42%-1.64M | -81.49%-8.12M | -1.63M | -2.46M |
| Net non-operating interest income (expenses) | -81.80%2.17K | -90.30%2.74K | -58.26%51.33K | -84.13%5.87K | -88.04%5.21K | -64.53%11.95K | 224.59%28.3K | 3,557.61%122.97K | 37.01K | 43.56K |
| Non-operating interest income | ---- | -90.30%2.74K | -58.26%51.33K | -156.89%-5.66K | -88.04%5.21K | ---- | 224.59%28.3K | --122.97K | --9.94K | --43.56K |
| Total other finance cost | 81.80%-2.17K | ---- | ---- | ---- | ---- | 64.53%-11.95K | ---- | -3,557.61%-122.97K | ---- | ---- |
| Other net income (expenses) | 586.70%8.42K | -3,171.60%-10.6K | -17,768.75%-28.59K | -342.51%-22.12K | 56.99%-4.42K | -173.64%-1.73K | 76.12%-324 | -100.77%-160 | 9.12K | -10.27K |
| Gain on sale of security | 430.00%7.82K | -1,660.06%-11.19K | -1,366.04%-30.52K | -356.59%-22.71K | 56.36%-4.8K | -227.97%-2.37K | 64.21%-636 | -137.29%-2.08K | --8.85K | ---11.01K |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non-operating income (expenses) | -7.33%594 | 90.38%594 | 0.57%1.93K | 120.82%594 | -47.63%386 | 29.23%641 | -25.71%312 | -91.60%1.92K | --269 | --737 |
| Income before tax | 62.98%-422.33K | 73.63%-424.67K | 46.32%-4.3M | 23.45%-1.22M | 86.03%-339.23K | 36.47%-1.14M | 26.45%-1.61M | -79.71%-8M | -1.59M | -2.43M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 62.98%-422.33K | 73.63%-424.67K | 46.32%-4.3M | 23.45%-1.22M | 86.03%-339.23K | 36.47%-1.14M | 26.45%-1.61M | -79.71%-8M | -1.59M | -2.43M |
| Net income continuous operations | 62.98%-422.33K | 73.63%-424.67K | 46.32%-4.3M | 23.45%-1.22M | 86.03%-339.23K | 36.47%-1.14M | 26.45%-1.61M | -79.71%-8M | ---1.59M | ---2.43M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 62.98%-422.33K | 73.63%-424.67K | 46.32%-4.3M | 23.45%-1.22M | 86.03%-339.23K | 36.47%-1.14M | 26.45%-1.61M | -79.71%-8M | -1.59M | -2.43M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 62.98%-422.33K | 73.63%-424.67K | 46.32%-4.3M | 23.45%-1.22M | 86.03%-339.23K | 36.47%-1.14M | 26.45%-1.61M | -79.71%-8M | -1.59M | -2.43M |
| Diluted earnings per share | 0 | 0 | 50.00%-0.06 | 33.33%-0.02 | 75.00%-0.01 | 33.33%-0.02 | 33.33%-0.02 | -71.43%-0.12 | -0.03 | -0.04 |
| Basic earnings per share | 0 | 0 | 50.00%-0.06 | 33.33%-0.02 | 75.00%-0.01 | 33.33%-0.02 | 33.33%-0.02 | -71.43%-0.12 | -0.03 | -0.04 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.